Bradley Pharmaceuticals

Bradley Pharmaceuticals announces initiatives to enhance shareholder value

Published in Lab Business Week, October 1st, 2006

Bradley Pharmaceuticals, Inc., (BDY) announced initiatives to enhance long-term shareholder value as part of the company's existing strategic plan to improve and expand product offerings, strengthen our financial profile, increase alignment with shareholders' interests and focus intensely on operations.

These initiatives include:

1) In-license phase II and III drugs and develop and bring to market products with long-term intellectual property protection.

2) Expand existing partnerships and joint venture relationships with biotechnology companies.

3) Foster new strategic alliances that deliver a stronger product...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-10-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database